Linked Life Data

18239391

Source:http://linkedlifedata.com/resource/pubmed/id/18239391

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-7-29
pubmed:abstractText
Randomized clinical trials have reported low risks of bleeding in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients receiving triple antithrombotic treatment (aspirin, clopidogrel and heparin). As trial patients often differ substantially from unselected patients treated in routine clinical settings, we compared the incidence of bleeding in 'real-life patients' with the incidence in the CURE (Clopidogrel in Unstable Angina to Prevent Recurrent Events) trial.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1421-9751
pubmed:author
pubmed:copyrightInfo
(c) 2008 S. Karger AG, Basel.
pubmed:issnType
Electronic
pubmed:volume
111
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
41-6
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Incidence of bleeding in 'real-life' acute coronary syndrome patients treated with antithrombotic therapy.
pubmed:affiliation
Department of Internal Medicine, Silkeborg Hospital, Aarhus, Denmark.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't